I. Landells

发表

Clinical Insights About Topical Treatment of Mild-to-Moderate Pediatric and Adult Atopic Dermatitis

L. Guenther, C. Lynde, J. Bergman, 2019, Journal of cutaneous medicine and surgery.

Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label CADMUS Jr study

A. Paller, M. Song, L. Eichenfield, 2020, The British journal of dermatology.

Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study

K. Papp, M. Seyger, K. Unnebrink, 2019, The British journal of dermatology.

Update on Alefacept Safety

W. Gulliver, K. Papp, R. Bissonnette, 2009, Journal of cutaneous medicine and surgery.

Efficacy Outcomes in Patients Using Alefacept in the AWARE Study

H. Lui, R. Bissonnette, N. Shear, 2009, Journal of cutaneous medicine and surgery.

Clinical Experience with Alefacept in Canadian Patients with Psoriasis: The Amevive Wisdom Acquired from Real-world Evidence (AWARE) Study

R. Bissonnette, N. Shear, G. Searles, 2009 .

Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study.

A. Paller, A. Menter, L. Eichenfield, 2015, Journal of the American Academy of Dermatology.

Etanercept treatment for children and adolescents with plaque psoriasis.

A. Gottlieb, A. Paller, R. Langley, 2008, The New England journal of medicine.

Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial

K. Papp, K. Unnebrink, D. Thaçi, 2017, The Lancet.

Efficacy and safety of etanercept in children and adolescents aged > or = 8 years with severe plaque psoriasis.

A. Paller, G. Kricorian, B. Freundlich, 2010, European journal of dermatology : EJD.

High Prevalence of Psoriatic Arthritis in a Cohort of Patients with Psoriasis Seen in a Dermatology Practice

J. Sampalis, M. Khraishi, E. Rampakakis, 2012, Journal of cutaneous medicine and surgery.

Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study

M. Gooderham, J. Fowler, R. Bissonnette, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section I: Pathophysiology of Atopic Dermatitis and Implications for Systemic Therapy

M. Gooderham, C. Lynde, M. Kirchhof, 2018, Journal of cutaneous medicine and surgery.

Management of Pediatric Plaque Psoriasis using Biologics.

E. Pope, J. Bergman, I. Lara-Corrales, 2019, Journal of the American Academy of Dermatology.

Topical calcipotriene for morphea/linear scleroderma.

A. Paller, C. Langman, B. Cunningham, 1998, Journal of the American Academy of Dermatology.

AB0331 Incidence of malignancy in psoriatic and rheumatoid arthritis patients living in newfoundland and labrador

M. Khraishi, G. Mugford, I. Landells, 2018, Rheumatoid arthritis – comorbidity and clinical aspects.

Familial Pityriasis Rubra Pilaris: Case Report and Review

I. Landells, C. Anandakrishnan, Joshua M. Mercer, 2013, Journal of cutaneous medicine and surgery.

The role of the dermatologist in identification and treatment of the early stages of psoriatic arthritis.

M. Khraishi, I. Landells, C. MacCallum, 2008, Skin therapy letter.

The Electronic Psoriasis and Arthritis Screening Questionnaire (ePASQ): A Sensitive and Specific Tool to Diagnose Psoriatic Arthritis Patients

M. Khraishi, G. Mugford, I. Landells, 2011, Journal of cutaneous medicine and surgery.

The Self-Administered Psoriasis and Arthritis Screening Questionnaire (PASQ): A Sensitive and Specific Tool for the Diagnosis of Early and Established Psoriatic Arthritis

M. Khraishi, G. Mugford, I. Landells, 2010 .

Hidradenitis Suppurativa: A Novel Model of Care and an Integrative Strategy to Adopt an Orphan Disease

W. Gulliver, D. Morgan, I. Landells, 2018, Journal of cutaneous medicine and surgery.

Canadian Consensus on Skin Barrier Repair Therapy in Atopic Dermatitis

C. Lynde, I. Landells, R. Haber, 2012, Journal of cutaneous medicine and surgery.

A Prospective, Nonrandomized, Open‐Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis

M. Brin, D. Pariser, A. Hebert, 2015, Pediatric dermatology.

The Next Phase of Real-World Clinical Experience with Alefacept: The AWARE-2 Registry

R. Bissonnette, N. Shear, G. Searles, 2009, Journal of cutaneous medicine and surgery.

Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition

M. Wiseman, M. Gooderham, K. Papp, 2017, Journal of cutaneous medicine and surgery.

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis

M. Wiseman, M. Gooderham, L. Guenther, 2021, Frontiers in Medicine.

Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section IV: Consensus Statements on the Assessment and Management of Pediatric Atopic Dermatitis

J. Bergman, I. Lara-Corrales, D. Marcoux, 2019, Journal of cutaneous medicine and surgery.

Treatment of Acne Vulgaris and Prevention of Acne Scarring: Canadian Consensus Guidelines

Kevin C. Smith, H. Degreef, Y. Poulin, 2000, Journal of cutaneous medicine and surgery.

Treatment of hemangiomas in children.

I. Landells, 2001, Skin therapy letter.

Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section I: Overview of Pediatric Atopic Dermatitis

J. Bergman, I. Lara-Corrales, I. Landells, 2019, Journal of cutaneous medicine and surgery.

Oral Mucosal Lesions in a Somali Boy

I. Landells, J. Prendiville, 1994, Pediatric dermatology.

Web‐based continuing medical education (I): Field test of a hybrid computer‐mediated instructional delivery system

V R Curran, T Hoekman, W Gulliver, 2000, The Journal of continuing education in the health professions.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document

M. Wiseman, M. Gooderham, K. Papp, 2018, Journal of Cutaneous Medicine and Surgery.

Web‐based continuing medical education (II): Evaluation study of computer‐mediated continuing medical education

V R Curran, T Hoekman, W Gulliver, 2000, The Journal of continuing education in the health professions.

The AWARE Study: Methodology and Baseline Characteristics

H. Lui, W. Gulliver, K. Papp, 2009, Journal of Cutaneous Medicine and Surgery.

Patterns of Combination Therapy with Alefacept for the Treatment of Psoriasis in Canada in the AWARE Study

H. Lui, K. Papp, R. Bissonnette, 2009, Journal of cutaneous medicine and surgery.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis

M. Wiseman, M. Gooderham, K. Papp, 2018, Journal of cutaneous medicine and surgery.

Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition

M. Wiseman, M. Gooderham, K. Papp, 2017, Journal of cutaneous medicine and surgery.

Etanercept treatment for children and adolescents with plaque psoriasis.

A. Gottlieb, A. Paller, R. Langley, 2008, The New England journal of medicine.